|
Adverse Effects
Contributing journals to this collection:
JAMA & Archives Journals
Citations 101-110 of 1622 total displayed.
- Original Investigations
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing
- Michael A. Steinman; Gary E. Rosenthal; C. Seth Landefeld; Daniel Bertenthal; Peter J. Kaboli
Arch Intern Med 2009; 169: 1326-1332.
[Abstract]
[Full text]
[PDF]
[ eTable ]
- Invited Commentary
Agreement Between Drugs-to-Avoid Criteria and Expert Assessments of Problematic Prescribing—Invited Commentary
- Daniel S. Budnitz
Arch Intern Med 2009; 169: 1332-1334.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Overrides of Medication Alerts in Ambulatory Care
- Stephen N. Rosenberg; Maureen Sullivan; Iver A. Juster; Jeffrey Jacques
Arch Intern Med 2009; 169: 1337.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Consider the Content of Drug-Drug Interaction Alerts—Reply
- Thomas Issaac; Joel S. Weissman; Roger B. Davis; Michael Massagli; Adrienne Cyrulik; Daniel Z. Sands; Saul N. Weingart
Arch Intern Med 2009; 169: 1338-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Consider the Content of Drug-Drug Interaction Alerts
- Michelle Sweidan; James F. Reeve; Jonathan G. A. Dartnell
Arch Intern Med 2009; 169: 1338.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
FDA Focuses on Drugs and Liver Damage: Labeling and Other Changes for Acetaminophen
- Bridget M. Kuehn
JAMA 2009; 302: 369-371.
[Extract]
[Full text]
[PDF]
- Health Agencies Update
Leukotriene Inhibitor Warning
- Bridget M. Kuehn
JAMA 2009; 302: 375-b.
[Extract]
[Full text]
[PDF]
- Original Contributions
Hormone Therapy and Ovarian Cancer
- Lina Steinrud Mørch; Ellen Løkkegaard; Anne Helms Andreasen; Susanne Krüger-Kjær; Øjvind Lidegaard
JAMA 2009; 302: 298-305.
[Abstract]
[Full text]
[PDF]
- Corrections
Error in Trial Registration Number in: Effect of a Pharmacist on Adverse Drug Events and Medication Errors in Outpatients With Cardiovascular Disease
-
Arch Intern Med 2009; 169: 1184.
[Full text]
[PDF]
- Original Investigations
Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment
- Marcus Lind; Kurt Boman; Lars Johansson; Torbjörn K. Nilsson; Ann-Kristin Öhlin; Lisbeth Slunga Birgander; Jan-Håkan Jansson
Arch Intern Med 2009; 169: 1210-1215.
[Abstract]
[Full text]
[PDF]
|
Advertisement


|
|
|